CG dinucleotides enhance promoter activity independent of DNA methylation

Most mammalian RNA polymerase II initiation events occur at CpG islands, which are rich in CpGs and devoid of DNA methylation. Despite their relevance for gene regulation, it is unknown to what extent the CpG dinucleotide itself actually contributes to promoter activity. To address this question, we...

Full description

Saved in:
Bibliographic Details
Published inGenome research Vol. 29; no. 4; pp. 554 - 563
Main Authors Hartl, Dominik, Krebs, Arnaud R, Grand, Ralph S, Baubec, Tuncay, Isbel, Luke, Wirbelauer, Christiane, Burger, Lukas, Schübeler, Dirk
Format Journal Article
LanguageEnglish
Published United States Cold Spring Harbor Laboratory Press 01.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Most mammalian RNA polymerase II initiation events occur at CpG islands, which are rich in CpGs and devoid of DNA methylation. Despite their relevance for gene regulation, it is unknown to what extent the CpG dinucleotide itself actually contributes to promoter activity. To address this question, we determined the transcriptional activity of a large number of chromosomally integrated promoter constructs and monitored binding of transcription factors assumed to play a role in CpG island activity. This revealed that CpG density significantly improves motif-based prediction of transcription factor binding. Our experiments also show that high CpG density alone is insufficient for transcriptional activity, yet results in increased transcriptional output when combined with particular transcription factor motifs. However, this CpG contribution to promoter activity is independent of DNA methyltransferase activity. Together, this refines our understanding of mammalian promoter regulation as it shows that high CpG density within CpG islands directly contributes to an environment permissive for full transcriptional activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present addresses: 4European Molecular Biology Laboratory (EMBL), Genome Biology Unit, D-69117 Heidelberg, Germany; 5Department of Molecular Mechanisms of Disease, University of Zürich, 8057 Zürich, Switzerland
ISSN:1088-9051
1549-5469
DOI:10.1101/gr.241653.118